MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
18.44
-0.06 (-0.32%)
Oct 24, 2025, 4:00 PM EDT - Market closed
MediWound Market Cap
MediWound has a market cap or net worth of $236.43 million as of October 24, 2025. Its market cap has increased by 32.84% in one year.
Market Cap
236.43M
Enterprise Value
212.06M
1-Year Change
32.84%
Ranking
Category
Stock Price
$18.44
Market Cap Chart
Since March 20, 2014, MediWound's market cap has decreased from $262.70M to $236.43M, a decrease of -10.00%. That is a compound annual growth rate of -0.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 236.43M | 23.10% |
| Dec 31, 2024 | 192.06M | 104.85% |
| Dec 29, 2023 | 93.76M | 19.44% |
| Dec 30, 2022 | 78.50M | 22.08% |
| Dec 31, 2021 | 64.30M | -36.14% |
| Dec 31, 2020 | 100.69M | 19.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |